The role of 18fluorine-fluorodeoxyglucose positron emission tomography in the diagnosis, follow-up, and regulation of treatment in patients with cardiac sarcoidosis.

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Left ventricular hypertrophy and hypertrophic cardiomyopathy: new findings Imaging ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by